Literature DB >> 17491678

Spotlight on ethnomedicine: usability of Sutherlandia frutescens in the treatment of diabetes.

Charles Sia1.   

Abstract

Entities:  

Year:  2004        PMID： 17491678      PMCID： PMC1783542          DOI： 10.1900/RDS.2004.1.145

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN： 1613-6071


× No keyword cloud information.
  27 in total

1.  Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction.

Authors:  H Kaneto; J Fujii; T Myint; N Miyazawa; K N Islam; Y Kawasaki; K Suzuki; M Nakamura; H Tatsumi; Y Yamasaki; N Taniguchi
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

2.  Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes.

Authors:  S Lortz; M Tiedge; T Nachtwey; A E Karlsen; J Nerup; S Lenzen
Journal:  Diabetes       Date:  2000-07       Impact factor: 9.461

3.  The antiproliferative and immunotoxic effects of L-canavanine and L-canaline.

Authors:  Aimee K Bence; David R Worthen; Val R Adams; Peter A Crooks
Journal:  Anticancer Drugs       Date:  2002-03       Impact factor: 2.248

Review 4.  A new role for GABA: inhibition of tumor cell migration.

Authors:  Arturo Ortega
Journal:  Trends Pharmacol Sci       Date:  2003-04       Impact factor: 14.819

5.  Effect of pinitol treatment on insulin action in subjects with insulin resistance.

Authors:  A Davis; M Christiansen; J F Horowitz; S Klein; M K Hellerstein; R E Ostlund
Journal:  Diabetes Care       Date:  2000-07       Impact factor: 19.112

Review 6.  L-canaline: a potent antimetabolite and anti-cancer agent from leguminous plants.

Authors:  G A Rosenthal
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

Review 7.  Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.

Authors:  A Rabinovitch; W L Suarez-Pinzon
Journal:  Biochem Pharmacol       Date:  1998-04-15       Impact factor: 5.858

8.  The antioxidant potential of Sutherlandia frutescens.

Authors:  Antonio C Fernandes; A Duncan Cromarty; Carl Albrecht; Constance E Jansen van Rensburg
Journal:  J Ethnopharmacol       Date:  2004-11       Impact factor: 4.360

9.  Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine.

Authors:  N Yamamoto; N Mueller-Lantzsch; H zur Hausen
Journal:  Int J Cancer       Date:  1980-04-15       Impact factor: 7.396

10.  Inhibition of the growth of human pancreatic cancer cells by the arginine antimetabolite L-canavanine.

Authors:  D S Swaffar; C Y Ang; P B Desai; G A Rosenthal
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701
View more
  5 in total

1.  Sutherlandia frutescens: the meeting of science and traditional knowledge.

Authors:  Oluwaseyi M Aboyade; Gustav Styger; Diana Gibson; Gail Hughes
Journal:  J Altern Complement Med       Date:  2013-07-09       Impact factor: 2.579

2.  Effect of short term and chronic administration of Sutherlandia frutescens on pharmacokinetics of nevirapine in rats.

Authors:  Mukul Minocha; Nanda K Mandava; Deep Kwatra; Dhananjay Pal; William R Folk; Ravinder Earla; Ashim K Mitra
Journal:  Int J Pharm       Date:  2011-04-23       Impact factor: 5.875

3.  Effects of Sutherlandia frutescens extracts on normal T-lymphocytes in vitro.

Authors:  Mlungisi Ngcobo; Nceba Gqaleni; Paul K Chelule; Metse Serumula; Alain Assounga
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-10-02

4.  The immunomodulatory effects of Sutherlandia frutescens extracts in human normal peripheral blood mononuclear cells.

Authors:  Mlungisi Ngcobo; Nceba Gqaleni; Paul K Chelule; Metse Serumula; Alain Assounga
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-02-13

5.  The mutagenic and antimutagenic activity of Sutherlandia frutescens extracts and marker compounds.

Authors:  Siyabulela S B N Ntuli; Wentzel C A Gelderblom; David R Katerere
Journal:  BMC Complement Altern Med       Date:  2018-03-15       Impact factor: 3.659
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.